🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Day 1 #ESOC2025 Canadian Stroke Consortium European Stroke Org Happening day, bridging with TNK and EVT is better, low intensity monitoring after IVT is safe, tirofiban post IVT may be helpful, and prolonged anticoagulation is not helpful in CVST.

#ESOC2025 🦵🏽EECP for improve cerebral vasodilatory reserve (on SPECT) in ICAD patient 1hr/d, 5 times/week 122 randomized patients, 58y, 61%males ✅EECP was associated with significant improvement in hemodynamic parameters

#ESOC2025 ☎️#PINGS2 trial for ambulatory BP management using basic phones, nurse-led strategy in Ghana 🇬🇭 ✅1ry out BP<140/90 at 12m: 👉67 vs 43% p0,001

#ESOC2025 #DEMDAS explored risk factors for developing post stroke #dementia Key factors: 🧠Previous brain health 🧠Stroke related factors 🫀Vascular and cardio metabolic, particularly pre & diabetes, reduced HDL-C

#ESOC2025 #FAST trial explored the effects of a therapist-led, patient tailored, intervention aiming to reduce falls rate. 2/3 with previous fall 🚶🏽‍♂️The intervention was based on mobility, balance and self efficacy ✅33% reduction in rate of falls!!

#ESOC2025 #ESTREL: Levodopa/carbidopa for improvement of motor recovery after stroke 💪🏼1ry outcome: difference in Fugl Meyer motor score at 3m, 🎯 6 points ❎Results: 64 (placebo) vs 68 (levodopa) points -0.9 (-3.78 - 1.98) points. p 0,5

#ESOC2025 🚑#MSUTelemed 🇦🇺 Remote neurolgist assesment vs onboard Safety/Eficiency/Time metrics 🟰No differences in safety 🟰 No differences in mRS at 90d ✅Improve in resource utilization in telemed group

🧠🚑MAP-STROKE 🗺️ 👉🏻prehospital triage: AHA vs multivariable tool 👉🏻> benefit LVO 👉🏻> benefit rural

#ESOC2025 #CONVINCE Colchicine in 2ry stroke prevention 🧐Secondary analysis on CRP levels (2mg/L as threshold) 📉MACEs events rates lower in colchicine treated/low CRP level group HR 0.69 (0.49-0.97) p=0.03

#ESOC2025 CoVASC- ICH 🧠🩸 👉🏻 ICH <48 hs + mild/moderate/ severe athero : colchine 💊vs placebo 👉🏻feasible and safe 👉🏻 🟰MACE 👉🏻 No AIS both arms

#ESOC2025 #STATICH Antithrombotic treatment after ICH 1ry outcome: recurrent symptomatic ICH at 2y FU Antiplatelets vs no: 3 vs 1 Anticoagulation vs no: 1 vs 1 ☝️Underpowered to make clinical conclusions (just 134 patients, very few events)

#ESOC2023 👀TenCRAOS 👉🏻CRAO < 4.5 hs: TNK 💉 vs ASA 💊 👉🏻 NO diff visual acuity at 30 days 👉🏻 Safety concerns: 💉> mortality/ SAE Verdict 🟥

#ESOC2025 #ERASE_Stroke Edaravone (free radical scavenger) for neuroprotection in acute stroke 🇨🇳 💊initiated<24hr, for 28d 🎯1ry outcome: mRS </= 1 at 90d 307 pts each arm (~63yo, NIHSS 7) ✅Results: 65.4 vs 47.1% (OR 2.12, p<0.01) 🧐No ≠ NIHSS change 🩸No increase of sICH

#ESOC2025 CeresTandem ✅ 👉🏻◀️ retrospective study 👉🏻eCAS + EVT vs EVT alone 👉🏻🟢eCAS better clinical outcomes at 90d 👉🏻eCAS without > sICH 🩸 RCT needed

#ESOC2025 #DETERMINE trial explored an individualized MAP-BP management during EVT vs standard (140-180mmHg) ~69yo. NIHSS 15. 91% conscious sedation ❎The intervention did not result in better mRS at 90d (1ry outcome)

#ESOC2025 IRIS 🧠💉(⛔️ IL-6 in EVT) 👉🏻 Tocilizumab vs placebo 👉🏻 💉< core growth 👉🏻 🔴no diff in functional outcomes 👉🏻 safe

🎓Join our #June webinar series by World Stroke Academy: 🟢 Neuroimaging in Stroke – June 5 🟢 EVT Workshop (Paraguay) – June 11 🟢 #ESOC2025 Joint Roundtable European Stroke Org Stroke AHA/ASA - June 12 🔗Learn more & Register: world-stroke-academy.org #StrokeEducation #StrokeCare

#MondayTip The stroke pathway and #ESOC2025 result Last week, Helsinki brought together the world’s leading stroke experts—leaving us with new evidence, fresh questions, and future challenges. All with one goal: improving outcomes for our patients European Stroke Org

🧠 May #PaperOfTheMonth: #Tenecteplase before #Thrombectomy – a game changer or a clinical detour? 📝Prof. Octavio Pontes Neto breaks it down in his commentary: world-stroke-academy.org/news/paper-of-… 📄NEJM paper: nejm.org/doi/full/10.10… #StrokeEducation #StrokeCare #EndovascularTherapy